Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Bach et al v. Amedisys, Inc. et al
Case Number:
3:10-cv-00395
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Derivative Litigation
Judge:
Firms
- Ajubita Leftwich
- Bernstein Litowitz
- Bohrer Brady
- Butler Snow LLP
- Clayton Fruge
- Cohen Placitella
- Connolly Wells
- deGravelles & Palmintier
- Donald L. Beckner & Associates
- Due Guidry
- Faruqi & Faruqi
- Gaudry Ranson
- Harrell & Nowak
- Jones Day
- Kahn Swick
- King & Spalding
- Morrow Morrow
- Neblett Beard
- Odom & Des Roches
- Phelps Dunbar
- Pomerantz LLP
- Robbins Geller
- Robein Urann
- Squitieri & Fearon
- Troutman Pepper
- Wolf Popper
Companies
Sectors & Industries:
-
December 21, 2017
Firms Get $7.4M In Fees For $44M Medicare Fraud Settlement
Bernstein Litowitz Berger & Grossman LLP and other attorneys will get about $7.4 million in fees for securing a $43.75 million settlement for shareholders who claimed a health care provider and its executives covered up a Medicare fraud scheme that ultimately halved its stock price.
-
June 16, 2017
Amedisys Pays $44M To End Investors' Medicare Fraud Suit
Amedisys Inc. has agreed to pay $43.75 million to settle a shareholder suit alleging the health care provider and its top executives hid a Medicare fraud scheme that caused its stock prices to drop by half, ending the case after seven years of litigation and a trip to the Fifth Circuit.
-
August 23, 2016
Amedisys Can't Dodge Investor Suit Over Medicare Fraud
A Louisiana federal judge has ruled that Amedysis Inc. investors can proceed with a trimmed version of their proposed class action alleging the health care provider and its top executives hid a Medicare fraud scheme that caused the price of the company's stock to drop by half.
-
July 02, 2012
Judge Tosses Medicare Fraud Suit Against Amedisys
A Louisiana federal judge on Thursday granted home health care provider Amedisys Inc.'s motion to dismiss a consolidated class action alleging it and several executives improperly inflated Medicare reimbursements, saying the plaintiffs didn't make a strong case about the purported fraud.